Markella Zannikou

发表

Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial.

Atique U. Ahmed, R. Stupp, M. Tate, 2021, The Lancet. Oncology.

IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

C. Horbinski, A. Sonabend, I. Balyasnikova, 2023, Journal for ImmunoTherapy of Cancer.

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

P. Zhang, Junfei Zhao, A. Sonabend, 2023, Nature Communications.

Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label.

D. Simberg, I. Balyasnikova, Guankui Wang, 2021, ACS nano.

S100A8/A9 predicts response to PIM kinase and PD-1/PD-L1 inhibition in triple-negative breast cancer mouse models

Roman Camarda, S. Balakrishnan, Dai Horiuchi, 2024, Communications medicine.

S100A8/A9 predicts triple-negative breast cancer response to PIM kinase and PD-1/PD-L1 inhibition

Deepak Kanojia, Roman Camarda, S. Balakrishnan, 2023, bioRxiv.

Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells

J. Casal, I. Balyasnikova, J. Casal, 2020, Cancers.

Bi-Specific Killer Cell Engager Enhances NK Cell Activity against Interleukin-13 Receptor Alpha-2 Positive Gliomas

I. Balyasnikova, M. Zannikou, Joseph T Duffy, 2023, Cells.

Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma

Deepak Kanojia, I. Balyasnikova, P. Zhang, 2019, Proceedings of the National Academy of Sciences.

A New Mouse Model of Diffuse Midline Glioma to Test Targeted Immunotherapies

C. Horbinski, I. Balyasnikova, O. Becher, 2021 .

Interfering with Metabolic Profile of Triple-Negative Breast Cancer using Rationally-Designed Metformin Prodrugs.

A. Casini, I. Balyasnikova, W. Ang, 2021, Angewandte Chemie.